Red Arrow Therapeutics Inc. closes $4.5M Seed Extension round
BOSTON, April 23, 2024 /PRNewswire/ -- Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan.
- BOSTON, April 23, 2024 /PRNewswire/ -- Red Arrow Therapeutics Inc. closed a $4.5M Seed Extension round, raising from four, top-tier institutional investors in Japan.
- Participants of this round are:
The University of Tokyo Edge Capital Partners Co., Ltd.
OSAKA University Venture Capital Co., Ltd. - Emerging from the University of Tokyo's Cabral Lab in 2021, Red Arrow Therapeutics Inc. develops pH-sensing nanomedicine drug delivery technologies for multiple therapeutic areas such as oncology.
- The Seed extension round will allow Red Arrow Therapeutics to obtain key preclinical data on safety and efficacy of their lead compound, IL-12-loaded nanopolymeric micelles.